Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Will China Life's Goegraphic Concentration Limit Its Growth?

Published 09/28/2016, 10:40 PM
Updated 07/09/2023, 06:31 AM

On Sep 28, 2016, we issued an updated research report on China Life Insurance Co. Ltd. (NYSE:LFC) .

The Beijing-based life insurance company is China’s largest insurance asset management company of China. With its extensive distribution and customer service network, the company dominates the market in which it operates.

The life insurer continues to enhance its product portfolio through technological innovations and upgrades. Hence, the company remains well poised to cater to changing customer demands and keep pace with development of technology.

Notably, China Life was the first Chinese insurance company to obtain a private equity fund license and enter the private equity business in Aug 2011. The company’s strong brand name has cemented its goodwill and strong enterprise value, enabling it to be a trendsetter in its operational space.

The increase in earned premiums over the last few years clearly evidences the company’s solid revenue base. Though several insurers like CNO Financial Group Inc (NYSE:CNO) , James River Group Holdings Ltd (NASDAQ:JRVR) , ageas SA/NV (OTC:AGESY) have been hit hard by the persistently weak interest rates, China Life’s sustained premium growth has somewhat cushioned it from the adversity.

The company’s balance sheet strength has also mitigated its financial risk. The company’s strong liquidity has led to an improvement in its solvency. Furthermore, the insurer’s commendable debt servicing capability has found favor with investors. As of Jun 30, 2016, the company’s core solvency ratio increased to 298.32% and comprehensive solvency ratio was 329.09%.

China Life intends to invest more in business development initiatives. It plans to take a serious call on the weak implementation of strategies on its sales force, tapping opportunities in urban areas in order to stabilize growth has been another component of their plan.

However, the slowdown in the Chinese economy is a major headwind for this company as most its operations are confined to the nation itself. In addition, China Life needs to strengthen its cost-management initiatives to avoid capital erosion. Persistently weak cash inflow indicates the company’s waning operating efficiency.

China Life presently carries Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



CHINA LIFE INS (LFC): Free Stock Analysis Report

CNO FINL GRP (CNO): Free Stock Analysis Report

AGEAS-ADR (AGESY): Free Stock Analysis Report

JAMES RIVER GRP (JRVR): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.